Research progress of heteroresistance to carbapenems in Pseudomonas aeruginosa
Author:
Affiliation:

1.Department of Laboratory Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China;2.Department of Laboratory Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, China;3.Department of Laboratory Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510120, China

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Comments
    Abstract:

    Heteroresistance refers to the co-existence of bacterial resistance and sensitivity to certain antimicrobial agents in the same clone. Carbapenems are the preferred drugs for the treatment of infection caused by Pseudomonas aeruginosa. With the increasing use of carbapenems, isolation rate of carbapenem-heteroresistant Pseudomonas aeruginosa (CHPA) gradually increased. However, there is no standard, efficient and low-cost detection method for CHPA that can be applied in clinical practice, leading to the failure of detection and treatment for CHPA infection. This paper reviewed the definition and detection methods of heteroresistance, as well as resistance mechanism, clinical and epidemiological characteristics of CHPA, provide references for clinical diagnosis and treatment of CHPA infection.

    Reference
    Related
Get Citation

刘宇阳,陈茶,黄彬.铜绿假单胞菌对碳青霉烯类抗生素异质性耐药的研究进展[J].中国感染控制杂志英文版,2021,(8):763-768. DOI:10.12138/j. issn.1671-9638.20217348.
Yu-yang LIU, Cha CHEN, Bin HUANG. Research progress of heteroresistance to carbapenems in Pseudomonas aeruginosa[J]. Chin J Infect Control, 2021,(8):763-768. DOI:10.12138/j. issn.1671-9638.20217348.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:July 06,2020
  • Revised:
  • Adopted:
  • Online: September 06,2021
  • Published: